Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Autolus Therapeutics (NASDAQ:AUTL)  Shares Attract Positive Analyst Ratings Amid Volatility

William Blair reiterated its outperform rating on Autolus Therapeutics (NASDAQ:AUTL), reinforcing a broadly positive analyst sentiment for the clinical-stage biotech firm. Needham & Company echoed this view with a “buy” rating and a USD 10.00 price target, while Wells Fargo trimmed its target to …

Aditi Sarkar | 28 September 2025

First Commonwealth Financial Corporation (NYSE:FCF) Boosts Dividend, Approves USD 25Mn Share Buyback

First Commonwealth Financial Corporation (NYSE:FCF)operates as a financial holding company. Its subsidiaries include First Commonwealth Bank (FCB), First Commonwealth Insurance Agency, Inc. (FCIA), and FRAMAL. Through FCB, the company offers a broad range of consumer and commercial banking services.

Aditi Sarkar | 26 September 2025

Organogenesis (Nasdaq:ORGO) Reports Update on Second Phase 3 ReNu® Trial

Organogenesis Holdings Inc. (Nasdaq:ORGO) announced an update on its second Phase 3 randomized controlled trial (RCT) of ReNu®, a cryopreserved amniotic suspension allograft (ASA) for symptomatic knee osteoarthritis (OA). While the study did not achieve statistical significance for its primary endpoint, the results showed …

Team Kalkine | 26 September 2025

TC Properties (NYSE:LTC) Advances External Growth Strategy With 40M USD SHOP Acquisition

LTC Properties, Inc. (NYSE:LTC), a real estate investment trust focused on seniors housing and health care properties, announced the closing of a 40M USD Senior Housing Operating Portfolio acquisition. The purchase includes two assisted living and memory care communities in Kentucky totaling 158 units.

Team Kalkine | 26 September 2025

Global Markets Weekly Update: Inflation, Tariffs, and Fed Policy in Focus

Markets are awaiting key inflation data that could guide the Fed’s next moves, after strong GDP and lower jobless claims slightly dampened hopes for aggressive rate cuts. Investors still expect 25 bps cuts in both October and December. On trade, President Trump unveiled steep …

Team Kalkine | 26 September 2025

NASDAQ Biotech Stocks Soar on Clinical Advances and Strategic Shifts

Biotech stocks made headlines on Thursday, September 25, 2025, with standout performances driven by unique company developments and promising clinical progress. Despite a challenging market environment, PepGen Inc., HeartSciences Inc., and Jasper Therapeutics delivered remarkable gains, fueled by innovation, strategic pivots, and investor optimism. …

Team Kalkine | 26 September 2025

Lloyds Banking Group PLC (NYSE:LYG) Assigned "Moderate Buy" Consensus Rating by Analysts

Lloyds Banking Group PLC (NYSE:LYG) has been given a consensus rating of "Moderate Buy" by seven brokerages currently covering the stock, according to MarketBeat. Of the analysts, two rated the stock ashold, four provided abuyrecommendation, and one assigned astrong buy.

Aditi Sarkar | 26 September 2025

The Metal's Moment: Silver's Secular Awakening

Image Source: ShutterstockLong-Term Price Dynamics and BreakoutAn analysis of the monthly chart for silver reveals a significant development. For years, the price of silver consolidated within a broad symmetrical wedge pattern that began after the peak in 2011. Recently, the price has broken out …

Team Kalkine | 25 September 2025

Cautious Sentiment Amid Policy Uncertainty and Mixed Sector Moves

Index Update:Investors stayed cautious ahead of key economic data and Fed commentary, with focus on the potential for another rate cut next month. Intel gained nearly 4% premarket on reports it approached Apple for an investment, lifting Apple shares slightly. Lithium Americas surged 13% …

Team Kalkine | 25 September 2025

Evaxion A/S (Nasdaq:EVAX) Out-Licenses EVX-B3 Vaccine Candidate to MSD

Evaxion A/S (NASDAQ:EVAX), a clinical-stage TechBio company focused on AI-Immunology™ powered vaccines, announced that MSD (Merck & Co., Inc.) has exercised its option to license the vaccine candidate EVX-B3. As part of the agreement, Evaxion receives a $7.5 million cash payment and is eligible …

Team Kalkine | 25 September 2025
Support

Hi! How can we help you today?

Loading…